Nowadays, India is known as the so-called diabetes capital of the world. There are more than 77 million patients with diabetes, so effective and affordable medicines are always in demand. In the case of pharma professionals, this gives them a special chance to work with diabetic PCD companies as franchise partners and provide direct healthcare services to individuals.
Whether you are looking to enter into a cardiac diabetic PCD pharma franchise or want to add to your business portfolio, it is important to know what drugs are in this therapeutic sector and why they are significant. In this blog, we'll explore the best anti-diabetic medications every franchise owner must be aware of and also reveal their importance in a balanced product portfolio.
Before we delve into the list of the products, we should first discuss the relevance of the anti-diabetic drugs.
Chronic Demand: Diabetes is a long-term condition, which will need a constant supply of anti-diabetic medication.
Expanding Market: The Indian anti-diabetic market has the potential to expand at a CAGR of above 8% within the coming years due to urbanization and changing lifestyles.
Doctor Preference: Physicians will recommend brands they have faith in and that are known to be safe and effective, and this therefore means that franchise partners must fit into the existing firms.
Use: Metformin is commonly used as the initial medicine in diabetes type 2. It enhances the sensitivity of insulin and reduces the level of blood sugar.
Pros: Cheap, universal, and little chance of gaining weight.
Cons: May cause gastrointestinal side effects in some patients.
Use: These cause the pancreas to make more insulin.
Pros: It is affordable and effective in the moderate management of blood sugar.
Cons: There is a risk of hypoglycemia when doses are not well controlled.
Use: Glucose-regulating drugs of a newer generation that do not result in significant hypoglycemia.
Pros: It is well-tolerated, and it is frequently used in combination therapies.
Cons: It is more expensive than conventional.
Use: They assist the kidneys in removing extra glucose in the form of urine and decrease risks of cardiovascular diseases.
Pros: Dual advantage, it regulates blood sugar and heart condition.
Cons: The possibility of urinary tract infections.
Use: Necessary in type 1 diabetes and in severe cases of type 2 diabetes.
Pros: It works very well in managing glucose.
Cons: Injections are required and could reduce patient compliance.
Diabetes is not a solitary disease; it tends to cause cardiovascular complications. This is the reason cardiac diabetic PCD pharma franchise opportunities are popular. Anti-diabetic monotherapy combined with cardiac therapy provides a portfolio that has:
Comprehensive Care: The needs of patients who frequently need care in both conditions are addressed.
Greater Market Accessibility: Directing cardiologists and diabetologists at the same time.
Greater ROI: Prescription volumes are greater with combination therapies.
When it comes to collaborating with diabetic PCD companies for franchises, it is not merely stocking the most popular drugs but a wide and creative selection.
Oral antidiabetics (glimepiride combinations and metformin).
Modern treatments (DPP-4 inhibitors, SGLT2 inhibitors).
Insulins and analogs.
Aids (glucometer strips, supplements).
The company you are working with matters a lot in terms of the quality of your product portfolio. Here’s what to evaluate:
WHO-GMP and DCGI authorizations ensure the safety and effectiveness of products.
You must partner with the best PCD pharma franchise on monopoly basis. This means there's limited competition in your area.
The existence of a powerful partner does not merely offer anti-diabetic products but offers other therapeutic lines such as antibiotics, and hence, it is easier to expand. For example, to add to your diabetic care portfolio, consider an antibiotics franchise in India.
The cooperation with the best PCD pharma company will make your position more acceptable among doctors and patients.
The scope is enormous. As the number of diabetes cases in India has been increasing drastically, franchise owners will have guaranteed demand, high prescription rates, and long-term profitability.
Since heart-related problems affect the majority of diabetic patients, including both types will make your portfolio more appealing to the prescribers.
Both have their place. Generics are affordable and in demand, whereas newer drugs serve premium consumers and doctors of specialized care.
Very important. Coming under a PCD pharma franchise means that you do not have to compete with the same company in your region.
The key to success in the diabetic care segment of franchise business is to understand your product portfolio. Combining the best anti-diabetic medications and heart medications, you will be able to address the needs of patients and guarantee steady growth.
Looking to become part of a major cardiac, diabetic, or PCD pharma franchise? Contact Iscon Life Sciences Pvt. Ltd. today and get yourself a step closer to a lucrative future in the healthcare industry.
Your email address will not be published. Required fields are marked *
